₹601.20
+10.40 (+1.76%)
As of 18 Sept 2026, Lincoln Pharmaceuticals Ltd share price is ₹601.20. The stock opened at ₹601.20 and had closed at ₹590.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹439.95 and a high of ₹770.00. In terms of performance, Lincoln Pharmaceuticals Ltd share price has decreased by 1.34% over the past six months and has increased by 6.69% over the last year.
LINCOLN Stock Price Chart
Lincoln Pharmaceuticals Ltd Overview
Market cap₹1,183 Crs
Volume1,273
Prev. Close₹590.80
Year range₹439.95 - ₹770.00
ISININE405C01035
About LINCOLN
Lincoln Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products.
Lincoln Pharmaceuticals Ltd Historical Performance
1 Month Return-5.03%
6 Month Return1.16%
3 Year Return14.95%
3 Month Return-8.61%
1 Year Return6.76%
5 Year Return54.42%
Lincoln Pharmaceuticals Ltd Fundamentals
ROCE(TTM)15.18%
P/E Ratio (TTM)12.27
P/B Ratio1.56
Debt to Equity0.01
ROE11.60%
EPS (TTM)48.15
Dividend Yield0.30%
Book Value378.25
Profit Margin13.89%
Operating Margin12.45%
Lincoln Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 704.48 | 645.71 | 614.97 | 532.79 | 482.08 |
| EBITDA | 131.14 | 123.97 | 134.32 | 111.66 | 105.47 |
| Net Profit | 87.89 | 82.35 | 93.30 | 72.90 | 69.36 |
| EPS | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
Lincoln Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 584.57 |
| Resistance 1 (R1) | 600.57 |
| Pivot Point | 594.33 |
Lincoln Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 11-Sep-2026 | 28-May-2026 | 11-Sep-2026 | Final | ₹1.80 |
| 12-Sep-2025 | 22-May-2025 | 12-Sep-2025 | Final | ₹1.80 |
| 13-Sep-2024 | 16-May-2024 | 14-Sep-2024 | Final | ₹1.80 |
| 15-Sep-2023 | 25-May-2023 | 16-Sep-2023 | Final | ₹1.50 |
| 15-Sep-2022 | 19-May-2022 | 17-Sep-2022 | Final | ₹1.50 |
LINCOLN Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Kishorbhai M Shah | Chairman |
| Mahendra G Patel | Managing Director |
| Hasmukhbhai I Patel | WTD & Executive Directorector |
Lincoln Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,855.30+0.10% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,300.00+1.55% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,815.00+0.05% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Lincoln Pharmaceuticals Ltd today is ₹601.20 on NSE and ₹601.20 on BSE.
- The 52-week high of Lincoln Pharmaceuticals Ltd is ₹770.00, while the 52-week low is ₹439.95.
- The current market capitalisation of Lincoln Pharmaceuticals Ltd is approximately ₹1,183 crore.
- The P/E (Price-to-Earnings) ratio of Lincoln Pharmaceuticals Ltd is 14.18. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Lincoln Pharmaceuticals Ltd is 1.74. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Lincoln Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for LINCOLN on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Lincoln Pharmaceuticals Ltd has delivered a return of approximately 14.95%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Lincoln Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.78% promoters, 4.60% FIIs, 0.27% DIIs, and 36.12% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
